The Competition Commission has confirmed it is actively investigating the South African subsidiary of the Indian generic drug manufacturer Hetero. They are looking into potential price collusion. This significant probe centres on the procurement of crucial HIV medication. Specifically, the combination pill tenofovir, lamivudine, and dolutegravir (TLD) is under review. Most HIV patients in the country take this three-in-one regimen.…